Canadian Firms, Govts Accused Over HIV Blood

28 April 1996

Armour Pharmaceutical (an affiliate of Rhone-Poulenc Rorer), Baxter Corp, Bayer Inc and Connaught Labs have been accused in Canada of continuing to distribute blood products which could transmit HIV and failing to warn consumers of the dangers after they had become aware of them.

The allegations are made in notices sent privately to the four companies by the Commission of Inquiry into the Blood System in Canada under Judge Horace Krever last December, but have now had to become public because the companies are seeking to have the notices overturned in the Federal Court. Notices have also been served on the federal government and eight provincial governments, the Canadian Red Cross Society and a number of individuals. They are bringing the joint action to ask the court to either overturn the notices or give them the opportunity to defend themselves.

The notices were sent under Section 13 of the federal Inquiries Act, which states that inquiry commissioners must inform any party in advance if they are to be accused of "allegations of potential misconduct" in the commission's final report.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight